In This Issue:
Investor Q&A; Key Regulatory Issues for Strategic Life Sciences Partnerships in China; Compulsory Patent Licensing in China; and New Developments on the “Patentable Subject Matter” Requirement of U.S....more
- Biotechnology China Compulsory Licenses Drug Manufacturers Foreign Copyright Protection Foreign Investment Licenses Life Sciences Patent-Eligible Subject Matter Patents Pharmaceutical
JD Supra gets your content noticed, increases your visibility and makes your marketing efforts hassle free...
Learn More or Schedule a demo